Research and Development

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …

US healthcare performance firm Medical Simulation Corporation has confirmed the appointment of Mary Beth Loesch as its president and chief executive. Loesch …

Chinese manufacturing and marketing firm Biostar Pharmaceuticals has hired professor Xiaohui Zheng as its chief scientist.Zheng is a professor and director of …

Charitable donations to a once obscure healthcare charity called the ALS Association have rocketed in August after its #IceBucketChallenge went …

The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …

A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …

Sartorius Stedim Biotech (SSB), a pharma and biotech supplier, today announced the appointment of Miriam Monge as director of marketing …

AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …